JPMorgan Mid Cap Growth Fund R5 EBIT

As of the most recent data (December 2023), JMGFX shows a EBIT of $2.4M. In the prior-year period, the figure was $0. That is above the sector sector average of $-25M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JMGFX's EBIT is now $2.4M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether JPMorgan Mid Cap Growth Fund R5 is outperforming or lagging.

The its sector sector average EBIT is about $-25M. JPMorgan Mid Cap Growth Fund R5 is at $2.4M, which is higher that average. That is roughly 109.6% above the sector mean. Use the comparison chart on this page to see how JMGFX stacks up against individual peers as well.

Tracking JMGFX's ebit over time shows whether JPMorgan Mid Cap Growth Fund R5 is scaling, shrinking, or reshaping that part of the business. The current reading is $2.4M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has JPMorgan Mid Cap Growth Fund R5's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $2.4M) with ownership activity and broader fundamentals.